Spectrum Pharmaceuticals, Inc.
SPPI · NASDAQ
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $52 | $40 | $56 | $26 |
| Short-Term Investments | $4 | $35 | $44 | $42 |
| Receivables | $34 | $14 | $1 | $1 |
| Inventory | $13 | $9 | $9 | $0 |
| Other Curr. Assets | $3 | $3 | $3 | $5 |
| Total Curr. Assets | $105 | $101 | $113 | $74 |
| Property Plant & Equip (Net) | $2 | $2 | $2 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $6 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | -$6 | $4 | $4 |
| Total NC Assets | $2 | $2 | $6 | $6 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $108 | $103 | $119 | $79 |
| Liabilities | – | – | – | – |
| Payables | $35 | $38 | $42 | $33 |
| Short-Term Debt | $1 | $1 | $1 | $1 |
| Tax Payable | $0 | $3 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $3 | $1 | $7 | $7 |
| Total Curr. Liab. | $39 | $43 | $50 | $41 |
| LT Debt | $29 | $29 | $28 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $13 | $4 | $5 | $5 |
| Total NC Liab. | $42 | $33 | $33 | $5 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $81 | $75 | $83 | $46 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,124 | -$1,119 | -$1,110 | -$1,088 |
| AOCI | -$3 | -$3 | -$3 | -$3 |
| Other Equity | $1,154 | $1,150 | $1,149 | $1,125 |
| Total Equity | $27 | $28 | $36 | $33 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $108 | $103 | $119 | $79 |
| Net Debt | -$23 | -$11 | -$27 | -$25 |